Recently, the oncogenic role of BPTF was reported in melanoma (Dar et al., 2015, Dar et al., 2016), pancreatic tumors, and Burkitt's lymphoma (Richart et al., 2016b), where BPTF was shown to promote the gene program related to tumor cell growth or survival such as c-MYC and BCL2. This evidence concerns the gene BCL2 and melanoma.